Skip to main content

Advertisement

Log in

Vascular endothelial growth factor-A gene electrotransfer promotes angiogenesis in a porcine model of cardiac ischemia

  • Original Article
  • Published:
Gene Therapy Submit manuscript

Abstract

This study aimed to assess safety and therapeutic potential of gene electrotransfer (GET) as a method for delivery of plasmid encoding vascular endothelial growth factor A (VEGF-A) to ischemic myocardium in a porcine model. Myocardial ischemia was induced by surgically occluding the left anterior descending coronary artery in swine. GET following plasmid encoding VEGF-A injection was performed at four sites in the ischemic region. Control groups either received injections of the plasmid without electrotransfer or injections of the saline vehicle. Animals were monitored for 7 weeks and the hearts were evaluated for angiogenesis, myocardial infarct size and left ventricular contractility. Arteriograms suggest growth of new arteries as early as 2 weeks after treatment in electrotransfer animals. There is a significant reduction of infarct area and left ventricular contractility is improved in GET-treated group compared with controls. There was no significant difference in mortality of animals treated with GET of plasmid encoding VEGF-A from the control groups. Gene delivery of plasmid encoding VEGF-A to ischemic myocardium in a porcine model can be accomplished safely with potential for myocardial repair and regeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 2013; 127: e6–e245.

    PubMed  Google Scholar 

  2. Mussolino M, Shurin SB . 2012 NHLBI Morbidity and Mortality Chart Book. 2013. NHLBI: Bethesda, MD, USA, 2014. Available from http://www.nhlbi.nih.gov/files/docs/research/2012_ChartBook_508.pdf.

  3. Krumholz HM, Merrill AR, Schone EM, Schreiner GC, Chen J, Bradley EH et al. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes 2009; 2: 407–413.

    Article  Google Scholar 

  4. Ross R . The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–809.

    Article  CAS  Google Scholar 

  5. Mukherjee D, Bhatt DL, Roe MT, Patel V, Ellis SG . Direct myocardial revascularization and angiogenesis—how many patients might be eligible? Am J Cardiol 1999; 84: 598–600; A8.

    Article  CAS  Google Scholar 

  6. Wolfram JA, Donahue JK . Gene therapy to treat cardiovascular disease. J Am Heart Assoc 2013; 2: e000119.

    Article  Google Scholar 

  7. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430–436.

    Article  CAS  Google Scholar 

  8. Mercola M, Ruiz-Lozano P, Schneider MD . Cardiac muscle regeneration: lessons from development. Genes Dev 2011; 25: 299–309.

    Article  CAS  Google Scholar 

  9. Ferrara N, Gerber HP, LeCouter J . The biology of VEGF and its receptors. Nat Med 2003; 9: 669–676.

    Article  CAS  Google Scholar 

  10. Liu W, Xu J, Wang M, Wang Q, Bi Y, Han M . Tumor-derived vascular endothelial growth factor (VEGF)-A facilitates tumor metastasis through the VEGF-VEGFR1 signaling pathway. Int J Oncol 2011; 39: 1213–1220.

    PubMed  Google Scholar 

  11. Folkman J . Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182–1186.

    Article  CAS  Google Scholar 

  12. Tang JM, Wang JN, Zhang L, Zheng F, Yang JY, Kong X et al. VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovasc Res 2011; 91: 402–411.

    Article  CAS  Google Scholar 

  13. Tao Z, Chen B, Tan X, Zhao Y, Wang L, Zhu T et al. Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proc Natl Acad Sci USA 2011; 108: 2064–2069.

    Article  CAS  Google Scholar 

  14. Chen Y, Amende I, Hampton TG, Yang Y, Ke Q, Min JY et al. Vascular endothelial growth factor promotes cardiomyocyte differentiation of embryonic stem cells. Am J Physiol Heart Circ Physiol 2006; 291: H1653–H1658.

    Article  CAS  Google Scholar 

  15. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005; 39: 733–742.

    Article  CAS  Google Scholar 

  16. Muller OJ, Katus HA, Bekeredjian R . Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc Res 2007; 73: 453–462.

    Article  Google Scholar 

  17. Yla-Herttuala S, Alitalo K . Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003; 9: 694–701.

    Article  Google Scholar 

  18. Ayuni EL, Gazdhar A, Giraud MN, Kadner A, Gugger M, Cecchini M et al. In vivo electroporation mediated gene delivery to the beating heart. PLoS One 2010; 5: e14467.

    Article  Google Scholar 

  19. Tevaearai HT, Gazdhar A, Giraud MN, Fluck M . In vivo electroporation-mediated gene delivery to the beating heart. Methods Mol Biol 2014; 1121: 223–229.

    Article  CAS  Google Scholar 

  20. Hargrave B, Downey H, Strange R Jr, Murray L, Cinnamond C, Lundberg C et al. Electroporation-mediated gene transfer directly to the swine heart. Gene Therapy 2013; 20: 151–157.

    Article  CAS  Google Scholar 

  21. Hargrave B, Strange R Jr, Navare S, Stratton M, Burcus N, Murray L et al. Gene electro transfer of plasmid encoding vascular endothelial growth factor for enhanced expression and perfusion in the ischemic Swine heart. PLoS One 2014; 9: e115235.

    Article  Google Scholar 

  22. Turillazzi E, Di Paolo M, Neri M, Riezzo I, Fineschi V . A theoretical timeline for myocardial infarction: immunohistochemical evaluation and western blot quantification for Interleukin-15 and Monocyte chemotactic protein-1 as very early markers. J Transl Med 2014; 12: 188.

    Article  Google Scholar 

  23. Logsdon EA, Finley SD, Popel AS, Mac Gabhann F . A systems biology view of blood vessel growth and remodelling. J Cell Mol Med 2014; 18: 1491–1508.

    Article  Google Scholar 

  24. [Anonymous]. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985; 312: 932–936.

    Google Scholar 

  25. Abraham J, Abraham TP . The role of echocardiography in hemodynamic assessment in heart failure. Heart Fail Clin 2009; 5: 191–208.

    Article  Google Scholar 

  26. Teichholz LE, Kreulen T, Herman MV, Gorlin R . Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37: 7–11.

    Article  CAS  Google Scholar 

  27. Dib N, Diethrich EB, Campbell A, Gahremanpour A, McGarry M, Opie SR . A percutaneous swine model of myocardial infarction. J Pharmacol Toxicol Methods 2006; 53: 256–263.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Mark Jaroszeski of University of South Florida, Tampa, FL, USA for design and construction of the electrode arrays used for gene electrotransfer. We also thank RaShae Cooke, Danielle Tajirian, Ben Cuffee and Ann Nix for providing excellent veterinary care to the animals throughout this study. We also thank Dr Robert Strange Jr of Portsmouth Naval Facility, Portsmouth, VA, USA and Dr Paul D Mahoney of Sentara Heart Hospital, Norfolk, VA, USA for surgical and arteriogram acquisition training. Funding for this work came from the National Institutes of Health R33 HL005441. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R Heller.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on Gene Therapy website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bulysheva, A., Hargrave, B., Burcus, N. et al. Vascular endothelial growth factor-A gene electrotransfer promotes angiogenesis in a porcine model of cardiac ischemia. Gene Ther 23, 649–656 (2016). https://doi.org/10.1038/gt.2016.35

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2016.35

  • Springer Nature Limited

This article is cited by

Navigation